December 2008
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|
| | 1 | 2 | 3 | 4 | 5 | 6 |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |
|
Clinical Trials Update: May 16, 2008
- Adenocarcinoma
- Migraine and Cluster Headaches
- Pancreatic Cancer
Fri May 16, 2008, 10:40
|
Story Tools
|
|
•
|
Printable
version
|
|
•
|
May 16, 2008 News
|
|
Related News Categories
| | • | Clinical Trials |
Related News
| • | Clinical Trials Update: Dec. 1, 2008 - Dec 01, 2008 | • | Hopes for AIDS Vaccine Still Alive Despite Setbacks - Dec 01, 2008 | • | Clinical Trials Update: Nov. 26, 2008 - Nov 26, 2008 | • | Clinical Trials Update: Nov. 25, 2008 - Nov 25, 2008 | • | Clinical Trials Update: Nov. 24, 2008 - Nov 24, 2008 | • | New Migraine Drug Shows Promise - Nov 24, 2008 | • | Clinical Trials Update: Nov. 21, 2008 - Nov 21, 2008 | • | Clinical Trials Update: Nov. 20, 2008 - Nov 20, 2008 | • | Clinical Trials Update: Nov. 17, 2008 - Nov 17, 2008 | • | Clinical Trials Update: Nov. 14, 2008 - Nov 14, 2008 | • | Clinical Trials Update: Nov. 13, 2008 - Nov 13, 2008 | • | Clinical Trials Update: Nov. 12, 2008 - Nov 12, 2008 | • | Clinical Trials Update: Nov. 11, 2008 - Nov 11, 2008 | • | Clinical Trials Update: Nov. 10, 2008 - Nov 10, 2008 | • | Clinical Trials Update: Nov. 7, 2008 - Nov 07, 2008 |
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Adenocarcinoma
This study will evaluate an investigational drug's effectiveness, when used in combination with other drugs, in slowing the progression of breast cancer. Participants must be at least 18, diagnosed with HER2-positive metastatic breast cancer, and be eligible for chemotherapy. The research site is in Jonesboro, Ark.
More information Please see http://www.centerwatch.com/patient/studies/cat546.html.
----- Migraine and Cluster Headaches
This study will evaluate an investigational medication to treat migraines. Participants must be at least 18, have a history of migraines for at least one year, and have had one to eight migraine attacks per month for the past two months. Participants will be compensated for time and travel. The research site is in Nashville, Tenn.
More information Please see http://www.centerwatch.com/patient/studies/cat100.html.
----- Pancreatic Cancer
This study will assess the safety and effectiveness of TNFerade in combination with 5-FU and radiation therapy as first-line treatments for unresectable locally advanced pancreatic cancer. Patients must be 18 or older, and additional eligibility criteria apply. The research site is in Los Angeles, Calif.
More information Please seehttp://www.centerwatch.com/patient/studies/cat35.html.
-----
Copyright 2008 Thomson CenterWatch. All rights reserved.
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Today's Top News Stories | • | FDA Touts Efforts to Enhance Food Safety - Dec 01, 2008, 17:00
Critics see problems with the agency's goals, commitment and resources. | • | Clinical Trials Update: Dec. 1, 2008 - Dec 01, 2008, 10:54
- Cervical Cancer
- Migraine and Cluster Headaches
- Hot Flashes
| • | Few Young Adults Seek Treatment for Psych Disorders - Dec 01, 2008, 17:00
Alcohol, nicotine use, personality illnesses common, study shows. | • | Antibiotics Largest Cause of Drug-Induced Liver Damage - Dec 01, 2008, 16:00
Prescription meds, supplements can also trigger acute organ failure, study says. | • | Hopes for AIDS Vaccine Still Alive Despite Setbacks - Dec 01, 2008, 09:00
The lesson from 2 failed trials: The science must be more vigorous, experts say. |
|
|
|
